Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Anthony Costales, MD
- Study ID
- NCT04586959
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Surgery with UM — DEVICEThe experimental group will have MIS with the placement of a uterine manipulator
- Surgery without UM — DEVICEThe control group will have MIS without the placement of a uterine manipulator
Study Details
This is a prospective, multi-center, randomized non-inferiority phase III study to evaluate if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed.
Key Dates
- Start date
- May 21, 2021
- Status verified
- Oct 2025
- Primary completion
- Jul 31, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 278 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Surgery With UM (Arm MAN UA)Subjects that undergo a MIS approach with a uterine manipulator (experimental arm)
- Active Comparator: Surgery Without UM (Arm Control)Subjects that undergo a MIS approach without a uterine manipulator (control arm)
Primary Outcome Measure
Positive peritoneal cytology (PC) [ Time Frame: Immediately after uterine manipulator placement in the manipulator group or prior to the initiation of the hysterectomy procedure in the non-manipulator group ]
Central Contacts
- Anthony Costales, MD713-798-3495
- Roberto Vargas, MD216-444-3414
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
| Baylor College of Medicine | Houston | Texas | 77030 | |
| Baylor College of Medicine- McNair Campus | Houston | Texas | 77030 | |
| Ben Taub General Hospital | Houston | Texas | 77030 | |
| Harris Health System - Smith Clinic | Houston | Texas | 77054 |
Find similar trials in Cleveland, OH
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersPHASE1/PHASE2 · Recruiting · Regeneron Pharmaceuticals · Birmingham, Alabama
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPHASE1/PHASE2 · Recruiting · Novartis Pharmaceuticals · Atlanta, Georgia